Genes in MS Patients Latham NY

Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports. "Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release.

Local Companies

Malta Animal Hospital
(518) 885-2550
604 State Route 67
Malta, NY
David Albert Clark
(518) 262-5333
47 New Scotland Ave
Albany, NY
Brown Integrated Chiropractic
(518) 213-0394
81 Miller Rd
Castleton On Hudson, NY
Mike Dudick, DC
(518) 664-2673
377 Route 146
Clifton Park, NY
Edward A Kinum
518-346-7076
201 Glen Ave. 
Scotia, NY
Frederick Wayne Van Saun
(518) 783-3110
1201 Troy Schenectady Rd
Latham, NY
Richard Sulkow, MD
(518) 271-3300
2215 Burdett Ave
Troy, NY
Paul Premsagar
(518) 442-5454
1400 Washington Ave
Albany, NY
Michael A Adamec
518-356-5623
1814 Curry Rd. 
Schenectady, NY
Dr. Joseph S. Gulyas
518-371-4800
2 Emma Lane
Clifton Park, NY
Data Provided by:
  

Provided By:

FRIDAY, Sept. 11 (HealthDay News) -- Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports.

"Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release. "This study asked, among those who have MS, why do some do well with the disease while others do poorly, and what might be the genetic determinants of this difference in outcome."

The study, which was scheduled to be presented Friday at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, identified two genes that appear to lead to repair of damage caused by multiple sclerosis in mice.

Multiple sclerosis affects about 330,000 people in the United States. The disease targets the central nervous system and damages the insulation that covers nerves. People with the disease suffer from a variety of symptoms, including loss of strength, vision, balance and muscle coordination.

"It's possible that the identification of these genes may provide the first important clue as to why some patients with MS do well, while others do not," Bieber said in the news release.

More information

Learn more about the disease from the National Multiple Sclerosis Society.

SOURCE: Mayo clinic, news release, Sept. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Genetic Clues for Skin Cancer Therapies Latham NY
Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.
- Doctor-Patient Talk for Hypertension Latham NY
- Gene Variants and Alzheimer's Risk Latham NY
- Side Effect Of Chemotherapy Drugs Latham NY
- Hospice: Getting Back Control of Your Life Latham NY
- Differences Between Hospice and Palliative Care Latham NY
- High Blood Pressure Genes Latham NY
- Depression in Heart Disease Patients Latham NY
- Gene Therapy for Parkinson's Latham NY
- Exercise for Chemotherapy Patients Latham NY